Entresto and Caffeine drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Entresto (sacubitril; valsartan) and Caffeine (caffeine). Common drug interactions include heart rate increased among females and burnout syndrome among males.

The phase IV clinical study analyzes what interactions people have when they take Entresto and Caffeine. It is created by eHealthMe based on reports of 15 people who take the same drugs from the FDA, and is updated regularly.

What is Entresto?

Entresto has active ingredients of sacubitril; valsartan. eHealthMe is studying from 126,629 Entresto users. Check the latest studies of Entresto.

What is Caffeine?

Caffeine has active ingredients of caffeine. It is often used in fatigue. eHealthMe is studying from 6,667 Caffeine users. Check the latest studies of Caffeine.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.



On Sep, 02, 2026

15 people who take Entresto and Caffeine together, and have interactions are studied.

Entresto and Caffeine drug interactions.

What are the common drug interactions of Entresto and Caffeine, by gender? *:

female:

  1. Heart rate increased
  2. Fluid retention (an abnormal accumulation of fluid in the blood)
  3. Hypoacusis (loss of hearing)
  4. Hypokinesia (decreased bodily movement)
  5. Insomnia (sleeplessness)
  6. Paraesthesia (sensation of tingling, tickling, prickling, pricking, or burning of a person's skin with no apparent long-term physical effect)
  7. Visual impairment
  8. Weight decreased
  9. Alopecia (absence of hair from areas of the body)
  10. Asthenia (weakness)

male:

  1. Burnout syndrome (problems related to life-management difficulty, but not considered a ""disorder)
  2. Dyspnoea (difficult or laboured respiration)
  3. Weight decreased
  4. Cough
  5. Fluid retention (an abnormal accumulation of fluid in the blood)
  6. Weight fluctuation
  7. Headache (pain in head)
  8. Dizziness
  9. Ejection fraction decreased (systolic heart failure)
  10. Bone disorder

What are the common drug interactions of Entresto and Caffeine, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

  1. Burnout syndrome (problems related to life-management difficulty, but not considered a ""disorder)
  2. Dyspnoea (difficult or laboured respiration)
  3. Cough
  4. Fluid retention (an abnormal accumulation of fluid in the blood)
  5. Weight fluctuation
  6. Dizziness

50-59:

  1. Cough
  2. Headache (pain in head)
  3. Renal impairment (severely reduced kidney function)
  4. Weight fluctuation
  5. Ejection fraction decreased (systolic heart failure)
  6. Aspartate aminotransferase increased
  7. Cardiac failure congestive
  8. Dehydration (dryness resulting from the removal of water)
  9. Gastroenteritis viral (inflammation of stomach and intestine caused by virus infection)
  10. Hypertension (high blood pressure)

60+:

n/a

What are the existing conditions these people have? *

  1. Cardiac Failure: 5 people, 33.33%
  2. Arthritis (form of joint disorder that involves inflammation of one or more joints): 3 people, 20.00%
  3. Skin Blushing/flushing (a sudden reddening of the face, neck): 2 people, 13.33%
  4. Weight Increased: 1 person, 6.67%
  5. Weight Fluctuation: 1 person, 6.67%

* Approximation only. Some reports may have incomplete information.

Do you take Entresto and Caffeine?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Entresto and Caffeine:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Entresto:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Caffeine:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Entresto and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Caffeine and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on sacubitril; valsartan and caffeine (the active ingredients of Entresto and Caffeine, respectively), and Entresto and Caffeine (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: